Secondary osteoporosis

PR Ebeling, HH Nguyen, J Aleksova… - Endocrine …, 2022 - academic.oup.com
Osteoporosis is a global public health problem, with fractures contributing to significant
morbidity and mortality. Although postmenopausal osteoporosis is most common, up to 30 …

Proton-pump inhibitors: understanding the complications and risks

P Malfertheiner, A Kandulski, M Venerito - … Reviews Gastroenterology & …, 2017 - nature.com
Proton-pump inhibitors (PPIs) are the most effective therapy for the full spectrum of gastric-
acid-related diseases. However, in the past decade, a steadily increasing list of …

American Thyroid Association statement on postoperative hypoparathyroidism: diagnosis, prevention, and management in adults

LA Orloff, SM Wiseman, VJ Bernet, TJ Fahey III… - Thyroid, 2018 - liebertpub.com
Background: Hypoparathyroidism (hypoPT) is the most common complication following
bilateral thyroid operations. Thyroid surgeons must employ strategies for minimizing and …

[HTML][HTML] Advantages and disadvantages of long-term proton pump inhibitor use

Y Kinoshita, N Ishimura, S Ishihara - … of neurogastroenterology and …, 2018 - ncbi.nlm.nih.gov
Proton pump inhibitors (PPIs) potently inhibit gastric acid secretion and are widely used for
treatment of acid-related diseases including gastroesophageal reflux disease and …

Adverse effects of proton pump inhibitors—evidence and plausibility

R Fossmark, TC Martinsen, HL Waldum - International journal of …, 2019 - mdpi.com
Proton pump inhibitors (PPIs) have been increasingly used over the last decades and there
are concerns about overuse and the numerous reported side-effects. It is uncertain whether …

Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies

TN Poly, MM Islam, HC Yang, CC Wu, YCJ Li - Osteoporosis International, 2019 - Springer
We performed a meta-analysis of relevant studies to quantify the magnitude of the
association between proton pump inhibitors (PPIs) and risk of hip fracture. Patients with PPIs …

Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies

WY Elaine, SR Bauer, PA Bain, DC Bauer - The American journal of …, 2011 - Elsevier
Background Concerns have been raised about the risk of fractures with acid-suppressive
medications, such as proton pump inhibitors and histamine 2-receptor antagonists. Methods …

Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study

H Khalili, ES Huang, BC Jacobson, CA Camargo… - Bmj, 2012 - bmj.com
Objective To examine the association between chronic use of proton pump inhibitors (PPIs)
and risk of hip fracture. Design Prospective cohort study. Setting Nurses' Health Study, which …

American association of clinical endocrinologists and American college of endocrinology disease state clinical review: postoperative hypoparathyroidism-definitions …

BC Stack Jr, DN Bimston, DL Bodenner, EM Brett… - Endocrine practice, 2015 - Elsevier
Abbreviations: BID= bis in die DSPTC= diffuse sclerosing papillary thyroid cancer FNA= fine-
needle aspiration HT= Hashimoto thyroiditis iPTH= intact parathyroid hormone 25OHD= 25 …

Treatment of vitamin D insufficiency in postmenopausal women: a randomized clinical trial

KE Hansen, RE Johnson, KR Chambers… - JAMA internal …, 2015 - jamanetwork.com
Importance Experts debate optimal 25-hydroxyvitamin D (25 [OH] D) levels for
musculoskeletal health. Objective To compare the effects of placebo, low-dose …